Pancreatic cancer is often called a 'silent cancer' because its symptoms can be vague or mistaken for other conditions - but ...

Real-world study compares the efficacy and safety of axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel), ...

The survival rate for children with a rare but deadly cancer could one day be improved by adding an existing drug—which is ...

Smaller businesses backed by the government’s Start Up Loans programme have higher survival rates than other businesses, ...

Children from low-income households are more likely to experience cancer relapse and face lower survival rates.

Progression-free survival was superior with first-line maintenance of palbociclib in HR-positive, HER2-positive metastatic ...

Cardiff Oncology's phase 2 trial of onvansertib in mCRC shows promising results, with improved response rates and potential ...

Not only are they the smallest among us, but premature children also face health and life challenges that make them the most ...

SAN ANTONIO -- The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy ...

The data include an interim look at the dose-escalation portion of a phase 2 trial assessing the adenosine A2A receptor ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.

The catching of six rare giant catfish in Cambodia in the space of five days, some weighing more than 120 kg (265 lbs), has ...